DICE Therapeutics, Inc.
DICE · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $2,198,024 | $1,352,083 | $1,417,453 | $760,098 |
| - Cash | $73,464 | $101,594 | $461,393 | $48,271 |
| + Debt | $12,580 | $12,937 | $13,265 | $13,587 |
| Enterprise Value | $2,137,140 | $1,263,426 | $969,325 | $725,414 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$34,129 | -$25,646 | -$19,056 | -$19,872 |
| % Margin | – | – | – | – |
| Net Income | -$34,816 | -$19,717 | -$22,615 | -$19,931 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.74 | -0.42 | -0.5 | -0.53 |
| % Growth | -76.2% | 16% | 5.7% | – |
| Operating Cash Flow | -$28,576 | -$22,436 | -$17,892 | -$15,324 |
| Capital Expenditures | -$1,829 | -$202 | -$437 | -$524 |
| Free Cash Flow | -$30,405 | -$22,638 | -$18,329 | -$15,848 |